Use of GLP-1 receptor drugs before hip replacement and surgery outcomes

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed among total hip arthroplasty (THA) candidates.

• The perioperative impact of GLP-1 RAs on patients undergoing total hip arthroplasty is not well understood.
• There is a growing interest in studying the effects of GLP-1 RAs in the context of surgical procedures.
• Further investigation is needed to clarify how GLP-1 RAs may influence outcomes during the perioperative period.

Simplified